Vanguard Group Inc Heron Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,720,176 shares of HRTX stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,720,176
Previous 8,615,922 1.21%
Holding current value
$14.6 Million
Previous $30.2 Million 42.45%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.73 - $3.67 $180,359 - $382,612
104,254 Added 1.21%
8,720,176 $17.4 Million
Q2 2024

Aug 13, 2024
BUY
$2.32 - $3.86 $1.16 Million - $1.93 Million
501,206 Added 6.18%
8,615,922 $30.2 Million
Q1 2024

May 10, 2024
SELL
$1.71 - $3.06 $383,375 - $686,039
-224,196 Reduced 2.69%
8,114,716 $22.5 Million
Q4 2023

Feb 14, 2024
BUY
$0.54 - $1.82 $91,601 - $308,730
169,632 Added 2.08%
8,338,912 $14.2 Million
Q3 2023

Nov 14, 2023
BUY
$0.97 - $1.8 $27,701 - $51,404
28,558 Added 0.35%
8,169,280 $8.41 Million
Q2 2023

Aug 14, 2023
SELL
$1.11 - $2.88 $321,784 - $834,900
-289,896 Reduced 3.44%
8,140,722 $9.44 Million
Q1 2023

May 15, 2023
BUY
$1.51 - $3.25 $942,742 - $2.03 Million
624,333 Added 8.0%
8,430,618 $12.7 Million
Q4 2022

Feb 10, 2023
SELL
$2.25 - $4.67 $2.13 Million - $4.42 Million
-946,556 Reduced 10.81%
7,806,285 $19.5 Million
Q3 2022

Nov 14, 2022
BUY
$2.66 - $5.37 $2.1 Million - $4.25 Million
790,644 Added 9.93%
8,752,841 $36.9 Million
Q2 2022

Aug 12, 2022
SELL
$2.3 - $6.29 $4.54 Million - $12.4 Million
-1,972,491 Reduced 19.85%
7,962,197 $22.2 Million
Q1 2022

May 13, 2022
BUY
$4.63 - $9.94 $1.51 Million - $3.24 Million
325,643 Added 3.39%
9,934,688 $56.8 Million
Q4 2021

Feb 14, 2022
BUY
$8.35 - $12.6 $908,087 - $1.37 Million
108,753 Added 1.14%
9,609,045 $87.7 Million
Q3 2021

Nov 12, 2021
BUY
$10.13 - $15.0 $1.83 Million - $2.71 Million
180,564 Added 1.94%
9,500,292 $102 Million
Q2 2021

Aug 13, 2021
BUY
$13.27 - $18.48 $124 Million - $172 Million
9,319,728 New
9,319,728 $145 Million

Others Institutions Holding HRTX

# of Institutions
180
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $200M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email